4.3 Review

Curcumin and Diabetes: A Systematic Review

Journal

Publisher

HINDAWI LTD
DOI: 10.1155/2013/636053

Keywords

-

Funding

  1. National Natural Science Foundation of China [NSFC81274041, NSFC81273995]
  2. International Cooperation Projects of MOE [2011DFA30920]
  3. key Drug Development Program of MOST [20122X09103201]
  4. 973 Program [2009CB522700]

Ask authors/readers for more resources

Turmeric (Curcuma longa), a rhizomatous herbaceous perennial plant of the ginger family, has been used for the treatment of diabetes in Ayurvedic and traditional Chinese medicine. The active component of turmeric, curcumin, has caught attention as a potential treatment for diabetes and its complications primarily because it is a relatively safe and inexpensive drug that reduces glycemia and hyperlipidemia in rodent models of diabetes. Here, we review the recent literature on the applications of curcumin for glycemia and diabetes-related liver disorders, adipocyte dysfunction, neuropathy, nephropathy, vascular diseases, pancreatic disorders, and other complications, and we also discuss its antioxidant and anti-inflammatory properties. The applications of additional curcuminoid compounds for diabetes prevention and treatment are also included in this paper. Finally, we mention the approaches that are currently being sought to generate a super curcumin through improvement of the bioavailability to bring this promising natural product to the forefront of diabetes therapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available